GlaxoSmithKline S.A.E (EGX:BIOC)
Egypt flag Egypt · Delayed Price · Currency is EGP
39.56
+0.31 (0.79%)
At close: Mar 27, 2025

GlaxoSmithKline S.A.E Ratios and Metrics

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
3,2573,0072,9693,1872,5791,416
Upgrade
Market Cap Growth
1.27%1.27%-6.84%23.57%82.08%-14.17%
Upgrade
Enterprise Value
3,3023,4302,7582,0792,8401,603
Upgrade
Last Close Price
39.0036.0034.6433.6026.2814.24
Upgrade
PE Ratio
18.7217.2849.114.3316.6850.35
Upgrade
PS Ratio
1.091.001.331.751.420.71
Upgrade
PB Ratio
1.631.511.511.841.901.17
Upgrade
P/TBV Ratio
1.511.511.512.002.311.45
Upgrade
P/FCF Ratio
-13.183.2316.49-
Upgrade
P/OCF Ratio
-9.823.0813.42-
Upgrade
EV/Sales Ratio
1.101.151.231.141.570.81
Upgrade
EV/EBITDA Ratio
6.887.365.7142.7910.206.94
Upgrade
EV/EBIT Ratio
7.738.056.15135.6811.737.92
Upgrade
EV/FCF Ratio
-6.25-12.252.1118.15-
Upgrade
Debt / Equity Ratio
0.060.060.050.040.130.12
Upgrade
Debt / EBITDA Ratio
0.250.250.201.070.600.63
Upgrade
Debt / FCF Ratio
--0.430.071.15-
Upgrade
Asset Turnover
0.830.830.660.650.800.89
Upgrade
Inventory Turnover
2.512.512.462.572.313.15
Upgrade
Quick Ratio
0.470.471.010.950.730.58
Upgrade
Current Ratio
1.821.821.881.761.531.44
Upgrade
Return on Equity (ROE)
8.79%8.79%3.27%-7.38%12.03%2.32%
Upgrade
Return on Assets (ROA)
7.38%7.38%8.32%0.34%6.66%5.62%
Upgrade
Return on Capital (ROIC)
12.74%12.74%14.53%0.57%10.45%9.01%
Upgrade
Return on Capital Employed (ROCE)
20.50%20.50%22.10%0.90%17.10%16.50%
Upgrade
Earnings Yield
5.34%5.79%2.04%23.08%6.00%1.99%
Upgrade
FCF Yield
-16.23%-17.58%7.58%30.98%6.07%-3.87%
Upgrade
Dividend Yield
1.92%-2.17%-2.85%-
Upgrade
Payout Ratio
40.05%40.05%217.67%15.10%3.61%19.84%
Upgrade
Total Shareholder Return
1.92%-2.17%-2.85%-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.